Literature DB >> 15071770

The prognostic value of glomerular immaturity in the nephrotic syndrome in children.

Danuta Ostalska-Nowicka1, Jacek Zachwieja, Janusz Maciejewski, Aldona Woźniak, Wiesława Salwa-Urawska.   

Abstract

The study group consisted of 16 children (9 boys and 7 girls) aged 6-52 months (mean age 27 months) with a first episode of nephrotic syndrome. Histological diagnosis (diffuse mesangial proliferation with signs of glomerular immaturity) was established by renal biopsy. The control group consisted of 47 children (26 boys and 21 girls) aged 7-58 months (mean 29 months) hospitalized with a first episode of nephrotic syndrome with diffuse mesangial proliferation, documented exclusively by histological examination. The aim of the study was to analyze the clinical course of a first episode of nephrotic syndrome in children with diffuse mesangial proliferation with and without signs of glomerular immaturity. In children with a first episode of the nephrotic syndrome and glomerular immaturity steroid resistance was more frequent (P=0.0234). Furthermore, in the study group there was a less favorable clinical course of the disease in children younger than 1 year of age and with an original serum albumin concentration lower than 1.0 g/dl. Hence, the presence of relatively rare signs of glomerular immaturity influences unfavorably the course and treatment of nephrotic syndrome in children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071770     DOI: 10.1007/s00467-004-1449-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  [Renal hypertension in children and adolescents].

Authors:  T Wyszyńska; A Wieteska-Klimczak
Journal:  Pol Arch Med Wewn       Date:  1998-09

2.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

3.  Histopathologic variability of the congenital nephrotic syndrome.

Authors:  E V Martul; M G Cuesta; I Churg
Journal:  Clin Nephrol       Date:  1987-10       Impact factor: 0.975

Review 4.  Immunosuppressive therapy in the nephrotic syndrome in children.

Authors:  R S Trompeter
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

5.  Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

Authors:  J Churg; R Habib; R H White
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

6.  Do current recommendations for kidney biopsy in nephrotic syndrome need modifications?

Authors:  Sanjeev Gulati; Ajay P Sharma; R K Sharma; Amit Gupta; R K Gupta
Journal:  Pediatr Nephrol       Date:  2002-06       Impact factor: 3.714

7.  The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome.

Authors:  R Waldherr; M C Gubler; M Levy; M Broyer; R Habib
Journal:  Clin Nephrol       Date:  1978-11       Impact factor: 0.975

8.  A clinicopathologic study of forty-eight infants with nephrotic syndrome.

Authors:  R K Sibley; J Mahan; S M Mauer; R L Vernier
Journal:  Kidney Int       Date:  1985-03       Impact factor: 10.612

9.  Mesangial deposits of IgM in patients with the nephrotic syndrome.

Authors:  F Mampaso; A Gonzalo; J Teruel; M Losada; N Gallego; J Ortuno; C Bellas
Journal:  Clin Nephrol       Date:  1981-11       Impact factor: 0.975

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  1 in total

1.  Is mesangial hypercellularity with glomerular immaturity a variant of glomerulosclerosis?

Authors:  Danuta Ostalska-Nowicka; Jacek Zachwieja; Michal Nowicki; Elzbieta Kaczmarek; Martin Witt
Journal:  Pediatr Nephrol       Date:  2007-01-19       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.